HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Domingo M. Braile Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moreira, L. F. P. Articles by Jatene, A. D. Search for Related Content PubMed PubMed Citation Articles by Moreira, L. F. P. Articles by Jatene, A. D.

Ann Thorac Surg 1996;61:408-412
© 1996 The Society of Thoracic Surgeons

---

Dynamic Myoplasty

Dynamic Cardiomyoplasty in South America

Instituto do Coração da Universidade de São Paulo, São Paulo and Hospital da Sociedade Portuguesa de Beneficencia, São José do Rio Preto, Brazil

Abstract

Background. Dynamic cardiomyoplasty has been proposed in the treatment of severe cardiomyopathies. However, few reports to date have shown significant numbers of patients collected on a multicenter basis.

Methods. From July 1987 to June 1994, dynamic cardiomyoplasty was performed in 112 patients in South America. The indications were dilated cardiomyopathy in 96 patients, Chagas' disease cardiomyopathy in 13, and ischemic cardiomyopathy in 3. Left latissimus dorsi muscle was used in all patients.

Results. The thirty-day mortality rate was 8.1%, and patients were followed up for 22.1 ± 18.6 months. Data of surviving patients show that 47.3% were in New York Heart Association functional class I, 45.6% in class II, and 7% in class III or IV 1 year after the operation. The 1-year survival was 78.4%; 2-year, 59.7%; and 5-year, 41.7%. The survival at 1 year was 86.1% for patients with dilated cardiomyopathy and 40% for those with Chagas' disease. At 5 years, these values were 49.8% and 9.5%, respectively. Long-term survival was also significantly affected by preoperative functional class and pulmonary vascular resistance. However, patients operated on in class III or intermittent class IV and without elevated pulmonary vascular resistance had survival rates of 91.5% at 1 year and 76.7% at 5 years of follow-up.

Conclusions. Cardiomyoplasty improves the functional status of patients with severe cardiomyopathies. Otherwise, long-term survival after this procedure is limited in patients with Chagas' disease and by patients' condition before the operation.

This article has been cited by other articles:

				A. Benicio, L. F. P. Moreira, F. Bacal, N. A. G. Stolf, and S. A. Oliveira Reevaluation of long-term outcomes of dynamic cardiomyoplasty Ann. Thorac. Surg., September 1, 2003; 76(3): 821 - 827. [Abstract] [Full Text] [PDF]

				L. F. P. Moreira, A. Benicio, F. Bacal, E. A. Bocchi, N. A.G. Stolf, and S. A. Oliveira Determinants of long-term mortality of current palliative surgical treatment for dilated cardiomyopathy Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 756 - 764. [Abstract] [Full Text] [PDF]

				G. Rigatelli, U. Carraro, M. Barbiero, R. Riccardi, F. Cobelli, M. Gemelli, and G. Rigatelli A Review of the Concept of Circulatory Bioassist Focused on the "New" Demand Dynamic Cardiomyoplasty: The Renewal of Dynamic Cardiomyoplasty? Angiology, May 1, 2003; 54(3): 301 - 306. [Abstract] [PDF]

				V. S Chekanov, D. E Sands, C. S Brown, F. Brum, P. Arzuaga, S. Gava, F. P Eugenio, V. Melamed, and H. W Spencer Cardiomyoplasty: First Clinical Case With New Cardiomyostimulator Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 264 - 266. [Abstract] [Full Text] [PDF]

				Y. Ootaki, M. Okada, T. Tsukube, and Y. Okita The Effect of Cardiomyoplasty on Left Atrial Function in Experimental Canine Models Chest, May 1, 2001; 119(5): 1526 - 1532. [Abstract] [Full Text] [PDF]

				M E Lewis, M P. Pitt, and R S Bonser Surgical alternatives to mechanical support Perfusion, July 1, 2000; 15(4): 379 - 386. [PDF]

				A. T. Ali, B. Y. Chiang, W. P. Santamore, R. D. Dowling, and A. D. Slater Preconditioning of the latissimus dorsi muscle in cardiomyoplasty: vascular delay or chronic electrical stimulation Eur. J. Cardiothorac. Surg., September 1, 1999; 14(3): 304 - 310. [Abstract] [Full Text] [PDF]

				M. A. Acker Dynamic cardiomyoplasty: at the crossroads Ann. Thorac. Surg., August 1, 1999; 68(2): 750 - 755. [Abstract] [Full Text] [PDF]

				A. T. Ali, W. P. Santamore, B. Y. Chiang, R. D. Dowling, G. R. Tobin, and A. D. Slater Vascular delay of the latissimus dorsi provides an early hemodynamic benefit in dynamic cardiomyoplasty Ann. Thorac. Surg., May 1, 1999; 67(5): 1304 - 1311. [Abstract] [Full Text] [PDF]

				N. A.G. Stolf, L. F. P. Moreira, E. A. Bocchi, M. de Lourdes Higuchi, F. Bacal, G. Bellotti, and A. D. Jatene Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy Ann. Thorac. Surg., November 1, 1998; 66(5): 1585 - 1591. [Abstract] [Full Text] [PDF]

				L. Aklog, F. Y. Chen, BrianJ. deGuzman, MichaelP. Murphy, WendelJ. Smith, RitaG. Laurence, RobertF. Appleyard, and L. H. Cohn Right Latissimus Dorsi Cardiomyoplasty Improves Left Ventricular Energetics Ann. Thorac. Surg., September 1, 1997; 64(3): 670 - 677. [Abstract] [Full Text]

				J. M. You, R. W. Landymore, and J. Fris Delayed Stimulation of the Latissimus Dorsi May Result in Disuse Atrophy Ann. Thorac. Surg., August 1, 1997; 64(2): 404 - 408. [Abstract] [Full Text]